Armenia has a population of around 3 million people and declared independence in 1991 after the fall of the Soviet Union. It has since transitioned to a market economy but remains a lower middle income country with over 40% of the population living below the poverty line. Healthcare is primarily funded through out-of-pocket payments which poses a large financial burden. Key health issues include noncommunicable diseases, tuberculosis, and low rates of immunization. The pharmaceutical market has grown in recent years but regulatory and financial challenges remain.

1. 2010
ARMENIA:in prospect

2. Armenian Pharmaceutical Market
The access to the pharmaceutical marketplace of any region is always paired with risks,
challenges and political, financial and economical factors specific to each region.
The Republic of Armenia is one of the Caucasus countries. With a surface area of Alcohol is not a big problem in Armenia so far; however, it is becoming more
29 800 km2, it is administratively divided into eleven provinces (marz), one of popular among those in the youngest age group (16–24)
which is the capital – Yerevan. The Republic of Armenia declared independence Unhealthy diet, obesity and low physical activity are common. Tuberculosis (TB)
in 1991 and entered a period of radical and fundamental political, social and has become an important public health problem with an estimated total
economic reforms. Despite some progress in setting up basic democratic and incidence of 77 new TB cases and 35 new pulmonary smear-positive TB cases per
market institutions, Armenia remains classified as a lower middle income 100 000. The prevalence of multi-drug-resistant TB is estimated to be 12% and
country, according to the World Bank index of "governance atmosphere", which 57% in new and previously-treated patients respectively. The DOTS (Directly
covers the effectiveness and quality of governance, rule of law, level of Observed Treatment, short course) is currently being implemented nationwide,
corruption, political stability, and civil liberties. The percentage of the including the penitentiary system. However, not all TB patients are properly
population living below the poverty line is 42.9 (UNDP Human Development registered and the case detection and treatment success rates are low
Report, 2004). Officially, services account for 40% of the GDP, industry for 25%,
The prevalence of HIV/AIDS in the adult population was about 0.1% in 2005.
the agricultural sector for 20% and construction for 15%.
Sixty-one percent of health funding is paid out of pocket at the point of service.
Demographic situation: The general mortality rate per 1000 increased from 5.7 in
This imposes a large barrier to health care access and a financial risk for many
1986 to 8.2 in 2005, and the natural growth rate of the population declined from
Armenians. Apart from foreign sources, the general tax revenue is the only pre-
18.3 to 3.5 per 1000.
paid source of health funding. However, the large share of unofficial out-of-
Main causes of mortality. Eighty-three per cent of deaths in Armenia are pocket payments (OOPs) and the low priority given to health by the
attributed to noncommunicable diseases followed by external causes (3%), Government limit the available public resources (1.64% of GDP, 2006)
communicable diseases (1%), and ill-defined conditions (4%). The leading causes
The Ministry of Health manages the health budget and the State Health Agency
of premature death (under 65) in Armenia are, in order of magnitude, diseases of
is responsible for purchasing a defined Basic Benefits Package (BBP) for the
the circulatory system, cancer, external injuries and poisoning.
population. In 2006, there was a 21% increase in the Government budget for the
Maternal and child health has improved in recent years. Although there is a health sector, most of which was spent on primary health care.
discrepancy between the nationally-reported data, WHO estimated data, and
data from various surveys, all sources testify to the declining trend in infant,
child, and maternal mortality Armenia:in prospect is available at
In spite of positive immunization .results (e.g. achievement of the status of a
polio-free region), the coverage rate of fully-immunized children, valid by Euros 145.00
recommended age, dropped to 42.3% in 2006 despite adequate vaccine supplies.
To know more about our report or to discuss this topic further
Lifestyle-associated health problems. Tobacco consumption is rising rapidly,
varying between 64.2% and 69.4% among men in the 24–65 years age group.
please do not hesitate to contact us
The prevalence of smoking among women is also on the rise, comprising 2.2%. Tel/Fax: +38 044 206 17 17/18
e-mail: office@smd.net.ua

3. Armenia:in prospect
EECCA: Region Features
Economic Development
Pharmaceutical Market: Executive Summary
Pharmaceutical Market: Main Features
Pharmaceutical Market: Structure
Per capita expenses
Armenia
Country profile
Economy
Healthcare system features
Healthcare system funding
The overall healthcare system structure
Healthcare system financial flowchart
Major local manufacturers
Armenia: Pharma Market
Main features
ATC 1 share. Total market, USD
ATC 1 share. Total market, Units
ATC 1 share. Rx segment, USD
ATC 1 share. Rx segment, Units
DISCLAIMER ATC 1 share. OTC segment, USD
All information contained in this publication ATC 1 share. OTC segment, Units
has been researched and compiled from sources
believed to be accurate and reliable at the time Leading corporations. Total market, USD
of publishing. However, SMD accepts no
Leading corporations. Total market, Units
liability whatsoever for any loss or damage
resulting from errors, inaccuracies or omissions Leading corporations. Rx segment, USD
affecting any part of the publication. All
information is provided without warranty, and
Leading corporations. Rx segment, Units
SMD makes no representation of warranty of Leading corporations. OTC segment, USD
any kind as to the accuracy or completeness of
any information hereto contained.
Leading corporations. OTC segment, Units
Armenia: Forecast for 2011-2013
Armenia:in prospect Pharmaceutical market, USD
© 2011 SMD
All information contained in this publication is copyrighted in the name of SMD (Support in Market Development), and as such no part of
this publication may be reproduced, repackaged, redistributed, resold in whole or in any part, or used in any form or by any means
graphic, electronic or mechanical, including photocopying, recording, taping, or by information storage or retrieval, or by any other means,
without the express written consent of the publisher.

4. SMD (Support in Market Development) - is a leading provider of market research,
sales management and forecasting services to the pharmaceutical industry.
Researches of:
· Pharmaceutics establishments' purchase and sale audit
· Hospital establishments' purchase audit
· Second distribution audit Ukraine, 03680
· Import medicine analyses Bojenko str., 86i, Kiev
· Doctor prescription analyses Tel/Fax: +38 044 206 17 17/18
· Ad Hoc research e-mail: office@smd.net.ua
· Analytical services http://www.smd.net.ua
Armenia:in prospect
April 2011